Searched for
TENALISIB
Rhizen receives USFDA orphan drug designation for cancer drugThe US Food and Drug Administration (USFDA) has granted orphan drug designation for Tenalisib (RP6530) for the treatment of patients with p...- Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater ChinaAs per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commerc...
- Rhizen receives USFDA orphan drug designation for cancer drugThe USFDA has granted orphan drug designation for Tenalisib (RP6530)... for the treatment of patients with peripheral T-cell lymphoma (PTCL...
- Rhizen receives USFDA fast track designation for cancer drugUSFDA has granted Fast Track Designation for RP6530.. for the treatment of patients with relapsed/refractory peripheral T- cell lymphoma (P...
Load More